Fealy S, Drakos M C, Allen A A, Warren R F
Department of Sports Medicine and Shoulder Service, Hospital for Special Surgery, Cornell University Medical Center, New York, NY 10021, USA.
Clin Orthop Relat Res. 2001 Sep(390):31-41.
The use of arthroscopic means to address shoulder instability has provided a technically advantageous way to approach Bankart lesions while posing complex questions regarding the specific indications for such an intervention. A successful outcome with arthroscopic Bankart repair is a function of proper surgical indication and patient selection. Several authors have evaluated the causes of failure and reasons for success with the Suretac device. The development of a bioabsorbable repair device at the authors' institution was precipitated by a desire to address and repair Bankart lesions arthroscopically while avoiding the frequent complications associated with the metal staple and the transglenoid suture technique. The Suretac represents the first generation of bioabsorbable transfixing devices. The initial objectives of the Suretac device were to adequately and dynamically tension soft tissue to bone, while providing a bioabsorption profile that mirrored the native healing response. The Suretac device is an appropriate surgical tool for arthroscopically repairing Bankart lesions in a carefully selected patient population.
使用关节镜手段治疗肩关节不稳为处理Bankart损伤提供了一种技术上更具优势的方法,但同时也带来了关于这种干预具体适应症的复杂问题。关节镜下Bankart修复术的成功结果取决于正确的手术适应症和患者选择。几位作者评估了使用Suretac装置失败的原因和成功的理由。作者所在机构开发一种生物可吸收修复装置的起因是希望在关节镜下处理和修复Bankart损伤,同时避免与金属吻合钉和经关节盂缝合技术相关的常见并发症。Suretac代表第一代生物可吸收固定装置。Suretac装置的最初目标是充分且动态地将软组织拉紧至骨组织,同时提供一种与天然愈合反应相似的生物吸收特性。Suretac装置是在经过精心挑选的患者群体中进行关节镜下修复Bankart损伤的合适手术工具。